Contest Trader

Don't miss the chance to cash-in prizes totaling

$10.000
Register here for the Ultimate demo trading competition

Stocks keep on gaining - Wednesday Review, November 11

Stocks keep on gaining - Wednesday Review, November 11

The potential COVID-19 vaccine moved the markets for the third consecutive day

The US

The benchmarks traded mixedly, part of them reacting to the fact that new restrictions might be imposed to curb the spread of COVID-19. On the other hand, others were driven by Microsoft and Apple's success following the launch of their new products. USA30 fell 0.08%, while USA500 gained 0.78%. TECH100 added 2.01%.

Crude settled up 1.5% at $41.99 per barrel. Brent rose 1% at $44.05.

Gold settled down 0.8% at $1,861.40 per ounce.

The Dollar Index traded at 92.741.

Asia and Australia

The markets closed higher over optimism that a viable COVID-19 vaccine could be successfully developed and launched. HongKong45 gained 2.24%.

Japan225 rose 5.41%.

Down under, Australia200 traded 1.79% higher.

Europe

Pfizer's potential COVID-19 still impacted the markets. Also, Europe was looking forward to Christine Lagarde's speech regarding the economic outlook and stimulus prospects. Europe50 climbed 0.4%. Germany30hit a one-month high after adding 0.56%. France40 went up 0.4%, while UK100 closed 0.2% higher.

EUR/USD closed at 1.1827 after it gained 0.1%.

Sources: investing.com, reuters.com

Maklumat yang disediakan oleh za.capex.com bukan berbentuk tawaran atau permintaan untuk tujuan pembelian atau penjualan apa-apa produk kewangan yang disebutkan di sini atau melibatkan perundngan, atau nasihat mahupun cadangan berkenaan dengan kewangan produk tersebut.

Maklumat ini disediakan untuk edaran umum. Ia tidak mengambil kira objektif pelaburan tertentu, keadaan kewangan atau keperluan tertentu dari mana-mana penerima.

Anda harus bebas menilai setiap produk kewangan dan mempertimbangkan kesesuaian produk kewangan sedemikian, dengan mengambil kira objektif pelaburan tertentu anda, keadaan kewangan atau keperluan khusus, dan berunding dengan penasihat kewangan bebas, sebelum berurusan dalam produk kewangan yang disebutkan dalam dokumen ini.

Maklumat ini tidak boleh diterbitkan, diedar semula, diterbitkan semula atau diedarkan secara keseluruhan atau sebahagian kepada mana-mana individu lain tanpa kebenaran bertulis daripada Syarikat terlebih dahulu.

Prestasi lalu tidak sentiasa menggambarkan prestasi atau kemungkinan masa depan. Sebarang pandangan atau pendapat yang dikemukakan hanyalah pandangan penulis semata-mata dan tidak mewakili za.capex.com